Level of HER2 gene amplification predicts response and overall survival in her2-positive advanced gastric cancer treated with trastuzumab Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal, Humanized
  • Gene Amplification
  • Receptor, ErbB-2
  • Stomach Neoplasms

abstract

  • The level of HER2 gene amplification significantly predicts sensitivity to therapy and overall survival in advanced gastric cancer treated with trastuzumab-based chemotherapy.

publication date

  • December 10, 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2013.48.9070

PubMed ID

  • 24127447

Additional Document Info

start page

  • 4445

end page

  • 52

volume

  • 31

number

  • 35